Table 1.
Receptor | Disease | Clinical features | References |
---|---|---|---|
GPR54 | Idiopathic hypogonadotropic hypogonadism | Attenuated secretion of GnRH, sexual development disruption | [215] |
PROKR2 | Kallmann syndrome | Impaired development of the olfactory system and reproductive axis | [271] |
FSHR | Oligospermia and subfertility Ovarian dysgenesis |
Small testes with impaired spermatogenesis in males Absence of follicular maturation in females |
[272] |
TSHR | Euthyroid hyperthyrotropinemia Congenital hypothyroidism |
TSH resistance with normal biological effects of TH TSH resistance with reduced biological effects of TH |
[234, 273] |
CaSR | Familial hypocalciuric hypercalcemia | Lifelong moderate elevation of serum calcium concentration and inappropriately normal PTH levels | [274, 275] |
Neonatal severe hyperparathyroidism | Neonatal marked elevation of serum calcium and PTH levels | ||
AVPR2 | Nephrogenic diabetes insipidus | Polyuria, polydipsia, hypernatremia, low urine osmolality, and AVP resistance | [236] |
MC1R | Pigmentation defect | Red hair color phenotype: red hair, fair skin, poor ability to tan, and increased risk of melanoma | [276] |
MC2R | Familial glucocorticoid deficiency | Low or undetectable cortisol levels and elevated ACTH levels | [277] |
MC4R | Obesity | Hyperphagia, increased fat and lean mass, and increased bone mass | [278] |
PTHR1 | Blomstrand chondrodysplasia | Advanced endochondral bone maturation associated with breast development and tooth impaction | [279, 280] |
Rhodopsin | Retinitis pigmentosa | Loss of vision, insensitivity in dim light | [16] |